SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease
Hille R., Hall J., and Basu P., The Mononuclear Molybdenum Enzymes, Chemical Reviews 114 (2014): 39634038, 10.1021/cr400443z
Gallbladder disease Cholelithiasis and cholecystitis have been reported, consistent with rapid weight loss generally
This is based on a widely held assumption that the body will convert what it needs to the biologically active form (T3)
H.ZhangJ.LiY.WuX
The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida